References
- 1. Almeida AM, Ramos F. Acute myeloid leukemia in the older adults. Leuk Res Rep. 2016;6:1-7. DOI: 10.1016/j.lrr.2016.06.00110.1016/j.lrr.2016.06.001492765527408788
- 2. Ofran Y, Tallman MS, Rowe J. How I treat acute myeloid leukemia presenting with preexisting comorbidities. Blood. 2016;128(4):488-96. DOI: 10.1182/blood-2016-01-63506010.1182/blood-2016-01-635060552453227235136
- 3. Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391-405. DOI: 10.1182/blood-2016-03-64354410.1182/blood-2016-03-64354427069254
- 4. Wang Y, Wu N, Liu D, Jin Y. Recurrent Fusion Genes in Leukemia: An Attractive Target for Diagnosis and Treatment. Curr Genomics. 2017;18(5):378-384. DOI: 10.2174/138920291866617032911034910.2174/1389202918666170329110349563564429081694
- 5. Fu JF, Hsu HC, Shih LY. MLL is fused to EB1 (MAPRE1), which encodes a microtubule-associated protein, in a patient with acute lymphoblastic leukemia. Genes Chromosomes Cancer. 2005;43(2):206-10. DOI: 10.1002/gcc.2017410.1002/gcc.2017415751040
- 6. Kourlas PJ, Strout MP, Becknell B, Veronese ML, Croce CM, Theil KS et al. Identification of a gene at 11q23 encoding a guanine nucleotide exchange factor: evidence for its fusion with MLL in acute myeloid leukemia. Proc Natl Acad Sci U S A. 2000;97(5):2145-50. DOI: 10.1073/pnas.04056919710.1073/pnas.0405691971576810681437
- 7. Tripon F, Crauciuc GA, Moldovan VG, Bogliș A, Benedek IJ, Lázár E et al. Simultaneous FLT3, NPM1 and DNMT3A mutations in adult patients with acute myeloid leukemia - case study. Rev Romana Med Lab. 2019;27(3):245-54. DOI: 10.2478/rrlm-2019-002210.2478/rrlm-2019-0022
- 8. Vázquez-Reyes A, Bobadilla-Morales L, Barba-Barba C, Macías-Salcedo G, Serafín-Saucedo G, Velázquez-Rivera ME et al. Aneuploidy identification in pre-B acute lymphoblastic leukemia patients at diagnosis by Multiplex Ligation-dependent Probe Amplification (MLPA). Leuk Res. 2017;59:117-123. DOI: 10.1016/j.leukres.2017.05.02210.1016/j.leukres.2017.05.02228624713
- 9. Bănescu C. Do we really need genetic tests in current practice? Rev Romana Med Lab. 2019;27(1):9-14. DOI: 10.2478/rrlm-2019-001010.2478/rrlm-2019-0010
- 10. Bănescu C, Tripon F, Trifa AP, Crauciuc AG, Bogliș A, Lazar E et al. Presence of copy number aberration and clinical prognostic factors in patients with acute myeloid leukemia: an analysis of effect modification. Pol Arch Intern Med. 2019;129(12):898-906. DOI: 10.20452/pamw.1509310.20452/pamw.1509331808755
- 11. Ruminy P, Marchand V, Buchbinder N, Larson T, Joly B, Penther B et al. Multiplexed targeted sequencing of recurrent fusion genes in acute leukaemia. Leukemia. 2016;30(3):757-60. DOI: 10.1038/leu.2015.17710.1038/leu.2015.17726139430
- 12. Verschuur A. Acute monocytic leukemia. Orphanet Encyclopedia 2004. Available at https://www.orpha.net/data/patho/GB/uk-AMLM5.pdf. (Last time accesed on 22 dec. 19)
- 13. Bănescu C, Iancu M, Trifa AP, Cândea M, Benedek Lazar E, Moldovan VG et al. From Six Gene Polymorphisms of the Antioxidant System, Only GPX Pro198Leu and GSTP1 Ile105Val Modulate the Risk of Acute Myeloid Leukemia. Oxid Med Cell Longev. 2016;2016:2536705. DOI: 10.1155/2016/253670510.1155/2016/2536705470732526823947
- 14. Arber DA, Brunning RD, Le Beau MM, Falini B, Vardiman JW, Porwit A et al. Acute myeloid leukemia with recurrent genetic abnormalities. In Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO classification of tumors of haematopoietic and lymphoid tissues, Lyon: IARC. 2017, p 136-7.
- 15. Borowitz MJ, Bene MC, Harris NL, Porwit A, Matutes E. Arber DA. Acute leukemias of ambiguous lineage. In Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO classification of tumors of haematopoietic and lymphoid tissues, Lyon: IARC. 2017, p 183-4.
- 16. DiNardo DC, Pratz K, Pullarkat V, Jonas BA, Arellano M, Becker PS et al. Venetoclax combined with decitabine or azacytidine in treatment naïve, elderly patients with acute myeloid leukemia. Blood. 2019;133(1):7-17. DOI: 10.1182/blood-2018-08-86875210.1182/blood-2018-08-868752631842930361262
- 17. Chen Y, Kantarjian H, Pierce S, Faderl S, O’Brien S, Qiao W et al. Prognostic significance of 11q23 aberrations in adult acute myeloid leukemia and the role of allogeneis stem cell transplantation. Leukemia. 2013;27:836-42. DOI: 10.1038/leu.2012.31910.1038/leu.2012.319418153923135353
- 18. Shih LY, Liang DC, Fu JF, Wu JH, Wang PN, Lin TL et al. Characterization of fusion partner genes in 114 patients with de novo acute myeloid leukemia and MLL rearrangement. Leukemia. 2006 Feb;20(2):218-23. DOI: 10.1038/sj.leu.240402410.1038/sj.leu.240402416341046
- 19. Bogliş A, Tripon F, Bănescu C. The utility of molecular genetic techniques in craniosynostosis cases associated with intellectual disability. Rev Romana Med Lab. 2018;26(4):471-7. DOI: 10.2478/rrlm-2018-003310.2478/rrlm-2018-0033
- 20. Crauciuc GA, Tripon F, Bogliş A, Făgărăşan A, Bănescu C. Multiplex ligation dependent probe amplification - A useful, fast and cost-effective method for identification of small supernumerary marker chromosome in children with developmental delay and congenital heart defect. Rev Romana Med Lab. 2018;26(4):461-70. DOI: 10.2478/rrlm-2018-003210.2478/rrlm-2018-0032